Aumann Waitman K, Kazi Rafi, Harrington Amanda M, Wechsler Daniel S
Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States.
Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.
Oncol Rev. 2024 Aug 5;18:1427497. doi: 10.3389/or.2024.1427497. eCollection 2024.
Chromosome Region Maintenance 1 (CRM1), also known as Exportin 1 (XPO1), is a protein that is critical for transport of proteins and RNA to the cytoplasm through the nuclear pore complex. CRM1 inhibition with small molecule inhibitors is currently being studied in many cancers, including leukemias, solid organ malignancies and brain tumors. We review the structure of CRM1, its role in nuclear export, the current availability of CRM1 inhibitors, and the role of CRM1 in a number of distinct cellular processes. A deeper understanding of how CRM1 functions in nuclear export as well as other cellular processes may allow for the development of additional novel CRM1 inhibitors.
染色体区域维持蛋白1(CRM1),也称为输出蛋白1(XPO1),是一种通过核孔复合体将蛋白质和RNA转运到细胞质中起关键作用的蛋白质。目前,小分子抑制剂对CRM1的抑制作用正在包括白血病、实体器官恶性肿瘤和脑肿瘤在内的多种癌症中进行研究。我们综述了CRM1的结构、其在核输出中的作用、CRM1抑制剂的当前可得性,以及CRM1在一些不同细胞过程中的作用。更深入地了解CRM1在核输出以及其他细胞过程中的功能,可能有助于开发更多新型CRM1抑制剂。